{"id":"NCT01427803","sponsor":"Bayer","briefTitle":"Actual Use Trial of Naproxen Sodium","officialTitle":"An Actual Use Trial In A Simulated OTC Environment of an Extended-Release Over-the-Counter NSAID","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2011-09-02","resultsPosted":"2013-05-20","lastUpdate":"2015-10-15"},"enrollment":778,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Naproxen Sodium ER (BAYH6689)","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"}],"summary":"An actual use trial to demonstrate that consumers will not exceed the labeled daily dose of Aleve 24 Hour at an unacceptable rate. Two aspects of consumer use will be evaluated: 1) the frequency at which consumers exceed the label-defined daily dose, thus putting themselves at clinical risk, and 2) the reasons for exceeding the labeled daily dose.","primaryOutcome":{"measure":"Estimated Percentage of Misuse for Non-Therapeutic Reasons","timeFrame":"28 days","effectByArm":[{"arm":"Naproxen Sodium ER (BAYH6689)","deltaMin":6.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":5},"locations":{"siteCount":34,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":745},"commonTop":["nasopharyngitis","abdominal pain upper","headache","constipation","diarrhoea"]}}